GERN FY 2025 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$184M+138.8% YoY

Gross Profit

$179M97.4% margin

Operating Income

-$54M-29.3% margin

Net Income

-$86M-46.7% margin

EPS (Diluted)

$-0.13

Cash Flow

Operating Cash Flow

-$111M

Free Cash Flow

-$111M

Stock-Based Comp.

$88,000

Balance Sheet

Total Assets

$571M

Total Liabilities

$347M

Stockholders' Equity

$224M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$184M	$77M	+138.8%
Gross Profit	$179M	$76M	+136.5%
Operating Income	-$54M	-$174M	+69.0%
Net Income	-$86M	-$175M	+50.9%